Moleculin Biotech, Inc. (MBRX)
Nasdaq: MBRX · CIK 0001659617 · United States
Every official Moleculin Biotech, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MBRX filings
Moleculin Biotech, Inc. documents
- Moleculin Biotech, Inc. 10-K 2026MBRX 10-K 2026: annual report for fiscal 2026
- Moleculin Biotech, Inc. 10-K 2025MBRX 10-K 2025: annual report for fiscal 2025
- Moleculin Biotech, Inc. 10-K 2024MBRX 10-K 2024: annual report for fiscal 2024
- Moleculin Biotech, Inc. 10-K 2023MBRX 10-K 2023: annual report for fiscal 2023
- Moleculin Biotech, Inc. 10-K 2022MBRX 10-K 2022: annual report for fiscal 2022
- Moleculin Biotech, Inc. 10-Q 2026MBRX 10-Q 2026: quarterly report for fiscal 2026
- Moleculin Biotech, Inc. 10-Q 2025MBRX 10-Q 2025: quarterly report for fiscal 2025
- Moleculin Biotech, Inc. 10-Q 2024MBRX 10-Q 2024: quarterly report for fiscal 2024
- Moleculin Biotech, Inc. 10-Q 2023MBRX 10-Q 2023: quarterly report for fiscal 2023
- Moleculin Biotech, Inc. 10-Q 2022MBRX 10-Q 2022: quarterly report for fiscal 2022
- Moleculin Biotech, Inc. 8-K 2026MBRX 8-K 2026: current report for fiscal 2026
- Moleculin Biotech, Inc. 8-K 2025MBRX 8-K 2025: current report for fiscal 2025
- Moleculin Biotech, Inc. 8-K 2024MBRX 8-K 2024: current report for fiscal 2024
- Moleculin Biotech, Inc. 8-K 2023MBRX 8-K 2023: current report for fiscal 2023
- Moleculin Biotech, Inc. 8-K 2022MBRX 8-K 2022: current report for fiscal 2022
- Moleculin Biotech, Inc. DEF 14A 2026MBRX DEF 14A 2026: proxy statement for fiscal 2026
- Moleculin Biotech, Inc. DEF 14A 2025MBRX DEF 14A 2025: proxy statement for fiscal 2025
- Moleculin Biotech, Inc. DEF 14A 2024MBRX DEF 14A 2024: proxy statement for fiscal 2024
- Moleculin Biotech, Inc. DEF 14A 2023MBRX DEF 14A 2023: proxy statement for fiscal 2023
- Moleculin Biotech, Inc. DEF 14A 2022MBRX DEF 14A 2022: proxy statement for fiscal 2022
- Moleculin Biotech, Inc. Form 4 2026MBRX Form 4 2026: insider trading filing for fiscal 2026
- Moleculin Biotech, Inc. Form 4 2025MBRX Form 4 2025: insider trading filing for fiscal 2025
- Moleculin Biotech, Inc. Form 4 2024MBRX Form 4 2024: insider trading filing for fiscal 2024
- Moleculin Biotech, Inc. Form 4 2023MBRX Form 4 2023: insider trading filing for fiscal 2023
- Moleculin Biotech, Inc. Form 4 2022MBRX Form 4 2022: insider trading filing for fiscal 2022
- Moleculin Biotech, Inc. S-1 2026MBRX S-1 2026: registration statement for fiscal 2026
- Moleculin Biotech, Inc. S-1 2025MBRX S-1 2025: registration statement for fiscal 2025
- Moleculin Biotech, Inc. S-1 2024MBRX S-1 2024: registration statement for fiscal 2024
- Moleculin Biotech, Inc. S-1 2023MBRX S-1 2023: registration statement for fiscal 2023
- Moleculin Biotech, Inc. S-1 2022MBRX S-1 2022: registration statement for fiscal 2022
- Moleculin Biotech, Inc. 13F 2026MBRX 13F 2026: institutional holdings for fiscal 2026
- Moleculin Biotech, Inc. 13F 2025MBRX 13F 2025: institutional holdings for fiscal 2025
- Moleculin Biotech, Inc. 13F 2024MBRX 13F 2024: institutional holdings for fiscal 2024
- Moleculin Biotech, Inc. 13F 2023MBRX 13F 2023: institutional holdings for fiscal 2023
- Moleculin Biotech, Inc. 13F 2022MBRX 13F 2022: institutional holdings for fiscal 2022
More companies